Alltrna is a biotech company founded in 2018 that aims to pioneer tRNA therapeutics to treat rare and common human diseases driven by shared genetic mutations. They have mapped tRNA biology to design medicines and use machine learning tools to unlock the entire tRNA biology space. Their platform can advance a single tRNA medicine to restore disrupted protein production for thousands of diseases with the same underlying genetic mutation.